184
Participants
Start Date
November 9, 2016
Primary Completion Date
March 6, 2018
Study Completion Date
July 31, 2018
Levopront® syrup 30 mg/5 ml
The first study drug administration was performed at the clinical site on the day of randomization; the last study drug administration was performed in the evening before Day 8 (±1).
Libexin®
The first study drug administration was performed at the clinical site on the day of randomization; the last study drug administration was performed in the evening before Day 8 (±1). No chewing.
"State Public Healthcare Institution of Moscow City Clinical Hospital # 71 of Moscow Healthcare Department", Moscow
"The Laboratory of Pulmonology, State Budgetary Educational Institution of Higher Professional Education Moscow State Medical-Stomatological University n.a. A.I. Evdokimov under Ministry of Health of the Russian Federation (Clinical base of state budget", Moscow
"State Autonomous Healthcare Institution of Yaroslavl Region Clinical Hospital of Emergency care n.a. N.V. Solovyev", Yaroslavl
"Institute of Medical Research LLC", Saint Petersburg
"Saint-Petersburg State Healthcare Institution Nikolaevskaya Hospital", Saint Petersburg
"LLC Treatment-and-prophylactic institution on the Smolensk clinic", Smolensk
"State Budgetary Educational Institution of Higher Professional Education Ryazan' State Medical University n.a. academician I.P. Pavlov under Ministry of Health of the Russian Federation", Ryazan
"State Healthcare Institution Regional Clinical Hospital", Saratov
Dompé Farmaceutici S.p.A
INDUSTRY